Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects.

Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects.

A specific response of human serum neutralizing antibodies (nAb) to a conformational epitope as a result of vaccination of human subjects with the surface envelope glycoprotein (gp120) of HIV-1 has not previously been documented. Here, we used computational analysis to assess the epitope-specific re...

Full description

Bibliographic Details
Main Authors:	Evgeny Shmelkov, Arthur Nadas, James Swetnam, Susan Zolla-Pazner, Timothy Cardozo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3208624?pdf=render

Similar Items

Comparative magnitude of cross-strain conservation of HIV variable loop neutralization epitopes.
by: James Swetnam, et al.
Published: (2010-12-01)

Epitope exposure on functional, oligomeric HIV-1 gp41 molecules.
by: Sattentau, Q, et al.
Published: (1995)

P20-09. Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodies
by: Cardozo TJ, et al.
Published: (2009-10-01)

Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
by: Wang Shixia, et al.
Published: (2006-12-01)

The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodies
by: Dueñas-Decamp Maria J, et al.
Published: (2012-01-01)

Conservation of HIV-1 gp120 neutralizing epitopes after formalin inactivation.
by: Sattentau, Q
Published: (1995)

Cryptic determinant of α4β7 binding in the V2 loop of HIV-1 gp120.
by: Boonrat Tassaneetrithep, et al.
Published: (2014-01-01)

Characterization of gp120 and Its Single-chain Derivatives, gp120-CD4 and gp120-M9: Implications for Targeting the CD4i Epitope in HIV-1 Vaccine Design
by: Shiver John
Published: (2005-12-01)

P19-21. Sequence variability in the crown of the V3 loop of the HIV-1 envelope is clustered within a small 3D structural zone
by: Zolla-Pazner S, et al.
Published: (2009-10-01)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
by: Nika M. Strokappe, et al.
Published: (2019-06-01)

Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking
by: Chuang G, et al.
Published: (2012-09-01)

Computational prediction of neutralization epitopes targeted by human anti-V3 HIV monoclonal antibodies.
by: Evgeny Shmelkov, et al.
Published: (2014-01-01)

Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses
by: Susan Zolla-Pazner, et al.
Published: (2014-11-01)

Immunoinformatic Identification of Multiple Epitopes of gp120 Protein of HIV-1 to Enhance the Immune Response against HIV-1 Infection
by: Arslan Habib, et al.
Published: (2024-02-01)

Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
by: Kristina K Peachman, et al.
Published: (2015-01-01)

Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes.
by: Chitra Upadhyay, et al.
Published: (2020-12-01)

Antibodies to the CD4-binding site of HIV-1 gp120 suppress gp120-specific CD4 T cell response while enhancing antibody response
by: Hioe Catarina E, et al.
Published: (2008-07-01)

Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay
by: Rao M, et al.
Published: (2012-09-01)

Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells.
by: Thananchai, H, et al.
Published: (2009)

Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.
by: Raphael Gottardo, et al.
Published: (2013-01-01)

Effect of site-specific de-glycosylation on HIV gp120-specific CD4 T cell responses
by: Visciano Maria, et al.
Published: (2006-12-01)

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer.
by: Sattentau, Q, et al.
Published: (1995)

Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.
by: Sakaorat Lertjuthaporn, et al.
Published: (2018-08-01)

Characterization of RNA aptamers that bind to HIV-1 gp120
by: Cohen, C
Published: (2006)

Monoclonal antibodies to HIV-1 gp120: a request.
by: Moore, J, et al.
Published: (1993)

STRUCTURAL-ANALYSIS OF THE HIV-1 ENVELOPE GLYCOPROTEIN GP120
by: Moore, J, et al.
Published: (1993)

Behavioral Evidence for a Tau and HIV-gp120 Interaction
by: Murali Vijayan, et al.
Published: (2022-05-01)

NMR spectroscopy of HIV-1 gp120 outer domain
by: Sastry M, et al.
Published: (2012-09-01)

Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject.
by: Liuzhe Li, et al.
Published: (2012-01-01)

Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.
by: Samuele E Burastero, et al.
Published: (2011-01-01)

HIV-1 gp120 induces expression of IL-6 through a nuclear factor-kappa B-dependent mechanism: suppression by gp120 specific small interfering RNA.
by: Ankit Shah, et al.
Published: (2011-01-01)

Immunoprophylaxis against mother-to-child transmission of HIV-1.
by: Miroslaw K Gorny, et al.
Published: (2006-07-01)

HIV-1 gp120-mediated increases in IL-8 production in astrocytes are mediated through the NF-κB pathway and can be silenced by gp120-specific siRNA
by: Kumar Anil, et al.
Published: (2010-12-01)

Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
by: Parren, P, et al.
Published: (1998)

Structural Basis for Epitopes in the gp120 Cluster A Region that Invokes Potent Effector Cell Activity
by: William D. Tolbert, et al.
Published: (2019-01-01)

Diversification of specificity after maturation of the antibody response to the HIV gp41 epitope ELDKWA.
by: Henry N White, et al.
Published: (2012-01-01)

Bispecific Anti-HIV Immunoadhesins That Bind Gp120 and Gp41 Have Broad and Potent HIV-Neutralizing Activity
by: Seth H. Pincus, et al.
Published: (2021-07-01)

Evolution of the HIV-1 envelope glycoproteins with a disulfide bond between gp120 and gp41
by: Caffrey Michael, et al.
Published: (2004-03-01)

Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity.
by: Heidi E Drummer, et al.
Published: (2013-01-01)

HIV gp120: double lock strategy foils host defences.
by: Sattentau, Q
Published: (1998)